bluebird bio, Inc.
BLUEDelisted Jun 2, 2025- Industry
- Biological Products, (No Diagnostic Substances)
- SEC CIK
- 0001293971
bluebird bio, Inc. was delisted on Jun 2, 2025; its insiders filed their last Form 4 on Jun 3, 2025; 85 institutions reported holding it in 13F filings for Q1 2025, worth $17.1M in total; no superinvestor held it.
13F holders, Q1 2024
Institutional positions in bluebird bio, Inc. as of Mar 31, 2024. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
- Institutional holders
- 159
- −28 vs. Q4 2023
- Shares held
- 103.1M
- −27.5M (−21.0%) vs. Q4 2023
- Total value
- $131.6M
- −$48.6M (−27.0%) vs. Q4 2023
- New holders
- 25
- 63 more added
- Sold out
- 53
- 41 more reduced
1 institution that held it in Q4 2023 haven't filed for Q1 2024 yet. Not filing isn't selling, so they aren't counted as sold out or in the changes above.
Compare with Q4 2023: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting BLUE on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 0 | $0 |
| Q1 2026 | 0 | $0 |
| Q4 2025 | 0 | $0 |
| Q3 2025 | 0 | $0 |
| Q2 2025 | 3 | $6.89K |
| Q1 2025 | 85 | $17.1M |
| Q4 2024 | 83 | $23.8M |
| Q3 2024 | 140 | $32.9M |
| Q2 2024 | 152 | $77.2M |
| Q1 2024 | 159 | $131.6M |
| Q4 2023 | 188 | $180.2M |
| Q3 2023 | 170 | $272.7M |
| Q2 2023 | 177 | $308.6M |
| Q1 2023 | 180 | $309.5M |
| Q4 2022 | 186 | $470.5M |
| Q3 2022 | 163 | $414.9M |
| Q2 2022 | 156 | $227.9M |
| Q1 2022 | 178 | $300.5M |
| Q4 2021 | 176 | $581.9M |
| Q3 2021 | 200 | $996.6M |
| Q2 2021 | 235 | $1.70B |
| Q1 2021 | 235 | $1.58B |
Institutions, Q1 2024
Shares, value and share of portfolio for each institution holding bluebird bio, Inc.; share changes are against Q4 2023.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| Federated Hermes, Inc. | 0 | $0 | 0.00% | −4,826−100.0% | Sold out |
| Allspring Global Investments Holdings, LLC | 0 | $0 | 0.00% | −2,369−100.0% | Sold out |
| Signaturefd, LLC | 0 | $0 | 0.00% | −1,960−100.0% | Sold out |
| Belvedere Trading LLC | 0 | $0 | 0.00% | −1,713−100.0% | Sold out |
| Lindbrook Capital, LLC | 0 | $0 | 0.00% | −649−100.0% | Sold out |
| Comerica Bank | 0 | $0 | 0.00% | −605−100.0% | Sold out |
| Highlander Capital Management, LLC | 0 | $0 | 0.00% | −500−100.0% | Sold out |
| Naples Money Management LLC | 0 | $0 | 0.00% | −500−100.0% | Sold out |
| EverSource Wealth Advisors, LLC | 0 | $0 | 0.00% | −175−100.0% | Sold out |
| Boyd Watterson Asset Management LLC | 0 | $0 | 0.00% | −124−100.0% | Sold out |
| Planning Capital Management Corp | 0 | $0 | 0.00% | −48−100.0% | Sold out |
| Rocky Mountain Advisers, LLC | 0 | $0 | 0.00% | −18−100.0% | Sold out |
| Fairfield Financial Advisors, LTD | – | – | – | – | Not filed |